SNPs | Chr: BP (Build 37) | Locus | Effect/other allele | Transferrin (μmol/L) | Overall breast cancer | ER-positive breast cancer | ER-negative breast cancer | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Betab (SE) | P value | Betac (SE) | P value | Betac (SE) | P value | Betac (SE) | P value | ||||
rs744653 | 2: 190,378,750 | WDR75–SLC40A1 | T/C | 0.068 (0.010) | 1.35E−11 | −0.009 (0.009) | 0.3548 | −0.007 (0.011) | 0.500 | −0.016 (0.016) | 0.310 |
rs8177240 | 3: 133,477,701 | TF | T/G | −0.380 (0.007) | 8.43E−610 | −0.014 (0.007) | 0.039 | −0.014 (0.008) | 0.072 | −0.012 (0.012) | 0.304 |
rs9990333 | 3: 195,827,205 | TFRC | T/C | −0.051 (0.007) | 1.95E−13 | −0.012 (0.007) | 0.059 | −0.015 (0.008) | 0.062 | −0.015 (0.012) | 0.210 |
rs1800562a | 6: 26,093,141 | HFE | A/G | −0.479 (0.016) | 8.90E−196 | −0.003 (0.014) | 0.831 | 0.010 (0.016) | 0.535 | −0.027 (0.025) | 0.288 |
rs1799945a | 6: 26,091,179 | HFE | C/G | 0.114 (0.010) | 9.36E−30 | −0.001 (0.009) | 0.913 | −0.003 (0.011) | 0.804 | −0.014 (0.016) | 0.380 |
rs4921915 | 8: 18,272,466 | NAT2 | A/G | 0.079 (0.009) | 7.05E−19 | −0.010 (0.007) | 0.187 | −0.012 (0.009) | 0.186 | −0.014 (0.013) | 0.295 |
rs174577 | 11: 61,604,814 | FADS2 | A/C | 0.062 (0.007) | 2.28E−17 | −0.006 (0.007) | 0.341 | 0.002 (0.008) | 0.761 | −0.033 (0.012) | 0.007 |
rs6486121 | 11: 13,355,770 | ARNTL | T/C | −0.046 (0.007) | 3.89E−10 | −0.004 (0.006) | 0.587 | −0.002 (0.007) | 0.809 | −0.009 (0.012) | 0.450 |
rs855791a | 22: 37,462,936 | TMPRSS6 | A/G | 0.044 (0.007) | 1.98E−09 | −0.003 (0.006) | 0.627 | 0.001 (0.008) | 0.852 | −0.013 (0.012) | 0.255 |